0001493152-24-015877.txt : 20240425
0001493152-24-015877.hdr.sgml : 20240425
20240425113644
ACCESSION NUMBER: 0001493152-24-015877
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240422
FILED AS OF DATE: 20240425
DATE AS OF CHANGE: 20240425
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: CZIRR JAMES C
CENTRAL INDEX KEY: 0001260641
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-31791
FILM NUMBER: 24874100
MAIL ADDRESS:
STREET 1: 4908 SOUTH ASHTON COURT
CITY: SPOKANE
STATE: WA
ZIP: 99223
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: GALECTIN THERAPEUTICS INC
CENTRAL INDEX KEY: 0001133416
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 043562325
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4960 PEACHTREE INDUSTRIAL BOULEVARD
STREET 2: SUITE 240
CITY: NORCROSS
STATE: GA
ZIP: 30071
BUSINESS PHONE: 678-620-3186
MAIL ADDRESS:
STREET 1: 4960 PEACHTREE INDUSTRIAL BOULEVARD
STREET 2: SUITE 240
CITY: NORCROSS
STATE: GA
ZIP: 30071
FORMER COMPANY:
FORMER CONFORMED NAME: PRO PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20010612
4
1
ownership.xml
X0508
4
2024-04-22
0
0001133416
GALECTIN THERAPEUTICS INC
GALT
0001260641
CZIRR JAMES C
4908 S. ASHTON CT.
SPOKANE,
WA
99223
0
0
1
0
0
Common Stock
2024-04-22
4
S
0
21323
3.06
D
5925884
I
By 10X Fund, LP
Common Stock
2024-04-23
4
S
0
3677
3.06
D
5922207
I
By 10X Fund, LP
The securities were sold by 10X Fund, LP. James C. Czirr is the manager of 10X Capital Management, LLC, which is the general partner of 10X Fund, L.P., a Delaware limited partnership, and as such Mr. Czirr may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P., but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
/s/ James C. Czirr, Individually
2024-04-25